Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

Recent Updates on Mechanisms of Resistance to 5-Fluorouracil and Reversal Strategies in Colon Cancer Treatment

Open access
Azwar, Shamin, Seow, Heng Fong, Abdullah, Maha, Faisal Jabar, Mohd, Mohtarrudin, Norhafizah · 2021 · Biology

Abstract

5-Fluorouracil (5-FU) plus leucovorin (LV) remain as the mainstay standard adjuvant chemotherapy treatment for early stage colon cancer, and the preferred first-line option for metastatic colon cancer patients in combination with oxaliplatin in FOLFOX, or irinotecan in FOLFIRI regimens. Despite treatment success to a certain extent, the incidence of chemotherapy failure attributed to chemotherapy resistance is still reported in many patients. This resistance, which can be defined by tumor tolerance against chemotherapy, either intrinsic or acquired, is primarily driven by the dysregulation of various components in distinct pathways. In recent years, it has been established that the incidence of 5-FU resistance, akin to multidrug resistance, can be attributed to the alterations in drug transport, evasion of apoptosis, changes in the cell cycle and DNA-damage repair machinery, regulation of autophagy, epithelial-to-mesenchymal transition, cancer stem cell involvement, tumor microenvironment interactions, miRNA dysregulations, epigenetic alterations, as well as redox imbalances. Certain resistance mechanisms that are 5-FU-specific have also been ascertained to include the upregulation of thymidylate synthase, dihydropyrimidine dehydrogenase, methylenetetrahydrofolate reductase, and the downregulation of thymidine phosphorylase. Indeed, the successful modulation of these mechanisms have been the game plan of numerous studies that had employed small molecule inhibitors, plant-based small molecules, and non-coding RNA regulators to effectively reverse 5-FU resistance in colon cancer cells. It is hoped that these studies would provide fundamental knowledge to further our understanding prior developing novel drugs in the near future that would synergistically work with 5-FU to potentiate its antitumor effects and improve the patient’s overall survival.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/biology10090854

Cites

Statistics

Figures

Figure 1 Various key enzymes facilitate the mechanism of action (anabolism) of 5-FU in cancer cells and its elimination (catabolism) via the hepatic system.
Figure 1 Various key enzymes facilitate the mechanism of action (anabolism) of 5-FU in cancer cells and its elimination (catabolism) via the hepatic system.CC BY · PubMed Central
Figure 2 Recent discoveries on the classical drug resistance mechanisms involving 5-FU resistance in colon cancer cells.
Figure 2 Recent discoveries on the classical drug resistance mechanisms involving 5-FU resistance in colon cancer cells.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 343 · Cited by 173

Research works printed but not linked: 1

  1. Nie, 2019, Effects of DPYD and TS gene polymorphisms on chemosensitivity of 5-FU in advanced colorectal cancer, Int. J. Clin. Exp. Med., 12, 9380

Metadata

Authors
Azwar, S., Seow, H. F., Abdullah, M., Faisal Jabar, M., & Mohtarrudin, N.
Affiliations
  • Universiti Putra Malaysia (MY)
  • Department of Surgery, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang 43400, Malaysia
Corresponding author
Mohtarrudin, Norhafizah
Venue
Biology
Publisher
MDPI AG
Published
2021-08-31
Volume
10
Issue
9
Pages
854
ISSN
2079-7737 (ISSN-L)
OpenAlex
W3197833154
Cited by
173
References
343
Citations by year
2026: 28 · 2025: 47 · 2024: 49 · 2023: 28 · 2022: 19
FWCI
2.93
Type
journal article
Language
en
Open access
Locations
  • Biology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer therapeutics and mechanisms
Keywords
5-fluorouracil resistance, colon cancer, chemotherapy resistance mechanisms, reversal strategies, thymidylate synthase, dihydropyrimidine dehydrogenase, methylenetetrahydrofolate reductase, thymidine phosphorylase, apoptosis evasion, DNA repair, autophagy, epithelial-mesenchymal transition, cancer stem cells, tumor microenvironment, microRNA dysregulation, epigenetic modifications, redox imbalance, drug transport, small molecule inhibitors, phytochemicals, non-coding RNA, FOLFOX, FOLFIRI

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Recent Updates on Mechanisms of Resistance to 5-Fluorouracil and Reversal Strategies in Colon Cancer Treatment. https://app.cochat.ai/papers/10.3390/biology10090854
The paper
Azwar, S., Seow, H. F., Abdullah, M., Faisal Jabar, M., & Mohtarrudin, N. (2021). Recent Updates on Mechanisms of Resistance to 5-Fluorouracil and Reversal Strategies in Colon Cancer Treatment. Biology. https://doi.org/10.3390/biology10090854

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.